Laddar...
Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients
Background. Postoperative nausea and vomiting (PONV) are common adverse events with an incidence of up to 80% in high-risk patients. Ramosetron, a selective 5-HT(3) receptor antagonist, is widely used to prevent PONV. The purpose of this study was to evaluate the effective dose of ramosetron for the...
Sparad:
| I publikationen: | Biomed Res Int |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Hindawi Publishing Corporation
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4516817/ https://ncbi.nlm.nih.gov/pubmed/26258145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/951474 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|